title: Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France.
authors.affiliation: HEVA HEOR, Lyon, France.
authors.forename: S
authors.initials: S
authors.lastname: Roze
authors.affiliation: Medtronic France SAS, Boulogne-Billancourt, France.
authors.forename: V
authors.initials: V
authors.lastname: Payet
authors.affiliation: Medtronic France SAS, Boulogne-Billancourt, France.
authors.forename: F
authors.initials: F
authors.lastname: Debroucker
authors.affiliation: Medtronic International Sàrl, Tolochenaz, Switzerland.
authors.forename: Portu S
authors.initials: PS
authors.lastname: de
authors.affiliation: UMR CNRS 5558, Faculté de Médecine Laennec, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Cucherat